Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Fish and Richardson
Argus Health
Harvard Business School
US Army

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,980,171

« Back to Dashboard

Summary for Patent: 4,980,171

Title: Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
Abstract:The invention relates to oral pharmaceutical compositions comprising a diphosphonic acid derivative and sodium laurylsulfate in the amount of 1.5 to 6% by weight, relative to the diphosphonic compound.
Inventor(s): Fels; Jean-Pierre (Castelnau le lez, FR), Gromenil; Jean-Claude (Montbazin-Poussan, FR), Abramovici; Bernard (Juvignac, FR)
Assignee: Societe Anonyme dite : SANOFI (Paris, FR)
Application Number:07/333,966
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,980,171

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France88 04628Apr 07, 1988

International Patent Family for Patent: 4,980,171

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria73662► Subscribe
Australia3258889► Subscribe
Australia618796► Subscribe
Canada1327009► Subscribe
Germany68900994► Subscribe
Denmark166989► Subscribe
European Patent Office0336851► Subscribe
France2629716► Subscribe
Ireland60923► Subscribe
Ireland891103► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: